Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review | Zendy

Gatto Lidia | Zendy; Franceschi Enrico | Zendy; Tosoni Alicia | Zendy; Di Nunno Vincenzo | Zendy; Maggio Ilaria | Zendy; To Caterina | Zendy; Lodi Raffaele | Zendy; Agati Raffaele | Zendy; Bartolini Stefania | Zendy; Brandes Alba Ariela | Zendy

Open Access

Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review

Author(s) -

Gatto Lidia,

Franceschi Enrico,

Tosoni Alicia,

Di Nunno Vincenzo,

Maggio Ilaria,

To Caterina,

Lodi Raffaele,

Agati Raffaele,

Bartolini Stefania,

Brandes Alba Ariela

Publication year - 2021

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.4604

Subject(s) - glioblastoma , medicine , regorafenib , hyperintensity , magnetic resonance imaging , fluid attenuated inversion recovery , radiology , bevacizumab , gadolinium dtpa , pathology , cancer research , chemotherapy , cancer , colorectal cancer

Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1‐weighted images and a simultaneous hyperintensity on T2‐weighted or fluid‐attenuated inversion recovery images.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research